Azithromycin, also known as Zithromax, belongs to the class of medicines known as antibacterials orantibiotics. These medicines kill bacteria (small organisms that can cause infection in humans) or stopbacteria from growing. Patients with weakened immune systems, includingpeople with HIV, tend to have more frequent andmore serious bacterial infections. Azithromycinwas approved by the FDA on June 14, 1996, formany uses, including the prevention and treatmentof Mycobacterium avium complex (MAC) inpersons with advanced HIV infection. It is alsobeing investigated to see how well it works inpreventing other kinds of bacterial infections inpeople with HIV.
A new research paper was published in Aging (listed by MEDLINE/PubMed as "Aging (Albany NY)" and "Aging-US" by Web of Science) Volume 15, Issue 21, entitled, "Antibiotics that target mitochondria extend lifespan in C. elegans."
The study reveals a post-pandemic rebound in antibiotic use across the EU/EEA, with 2022 levels returning to pre-COVID rates, highlighting the need for targeted interventions to meet antibiotic reduction goals by 2030.
A new study published today in the American Journal of Infection Control (AJIC) reveals that the use of doxycycline may help protect against Clostridioides difficile (C. diff) infection for some patients with pneumonia.
Researchers explores the application of antimicrobial stewardship in the antibiotic prescribing guidelines during the COVID-19 pandemic.
The largest-ever spatiotemporal monitoring of chemicals/contaminants of emerging concern (CECs) in London waterways.
Updated recommendations from the CDC on the use of pneumococcal vaccines in adults in the United States.
A preprint presents evidence for the hypothesis that neonatal sepsis is linked to prenatal antibiotics.
Researchers evaluate how the COVID-19 pandemic impacted antibiotic use in healthcare facilities throughout South America.
Overuse of antibiotics contributes to the problem of drug-resistant bacteria. Developing countries and young children are particularly affected. Review examines how antibiotics affect gut bacteria and drug resistance in infants in low- and middle-income countries.
Researchers evaluated the presence of coronavirus disease 2019 (COVID-19) drugs in river water.
Researchers highlighted the pace of development of COVID-19 therapies during the pandemic and the challenges that hinder the widespread availability of anticoronavirals.
Researchers examined the international dissemination of the outbreak of extensively drug-resistant Shigella sonnei.
In a recent study published in the journal Emerging Infectious Diseases, researchers analyzed ticks that bit humans between January 2014 and March 2021 in France for the presence of bacterial pathogens.
The Centers for Disease Control and Prevention (CDC) has classified Candida auris (C. auris) as an urgent public threat due to its role in elevating mortality, its ability to persist in hospital environments, and the high possibility of developing pan-drug resistance.
A large LSTM-led trial confirms new antimalarial, dihydroartemisinin-piperaquine, is more effective at preventing malaria than current WHO recommended treatment but does not improve adverse birth outcomes.
A single oral dose of the antibiotic azithromycin given during labor can dramatically reduce the risk of sepsis and death among women following childbirth, according to a large multi-country clinical trial, as a UN report warns of "stagnation" in maternal health.
In a research letter published in JAMA Health Forum, researchers evaluated antibiotic prescriptions during severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection-associated health visits in outpatient settings by United States (US) residents aged ≤64 years who have commercial health insurance.
Sepsis -; a severe infection in the body that can lead to tissue damage, organ failure, and death -; is among the top causes of maternal deaths worldwide, according to the World Health Organization (WHO).
A single dose of the antibiotic azithromycin can help protect mothers from dangerous sepsis infections and death during vaginal childbirth, a sweeping new international study from a UVA Health scientist and his collaborators has found.
Researchers report a rise in Shigella flexneri type 2a infections in men who have sexual intercourse with men in England from September 2021 onward.